Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 107671, 8 pages
http://dx.doi.org/10.1155/2014/107671
Research Article

Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation

1Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200127, China
2Department of Cell Biology, Key Laboratory of the Education Ministry for Cell Differentiation and Apoptosis, Institute of Medical Sciences, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China
3Department of Medicine and UC San Diego Moores Cancer Center, University of California, La Jolla, San Diego, CA 92093, USA

Received 8 June 2014; Revised 17 September 2014; Accepted 18 September 2014; Published 14 December 2014

Academic Editor: Zhenfeng Duan

Copyright © 2014 Jun Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Jun Ma, Jie Yang, Chao Wang, et al., “Emodin Augments Cisplatin Cytotoxicity in Platinum-Resistant Ovarian Cancer Cells via ROS-Dependent MRP1 Downregulation,” BioMed Research International, vol. 2014, Article ID 107671, 8 pages, 2014. https://doi.org/10.1155/2014/107671.